Breast cancer recurrence is one of the most feared aspects of breast cancer. According to a recent online article breast cancer recurrence may be predictable with a simple blood test using a DNA marker down through blood test researchers in Canada were able to accurately predict which women would be more likely to see a recurrence of their breast cancer years later. Admittedly more studies are needed to confirm these findings, but they do suggest that this blood test could complement current prognosis approach to the likelihood of the recurrence of breast cancer.Sambasivarao Damaraju, a professor with the Faculty of Medicine and Dentistry at Canada’s University of Alberta, and colleagues, write about their findings in the 16 January issue of the open access online journal PLoS ONE. Study authors conclude that current breast cancer reoccurrence prognosis use tumor-based assessments which they describe as “not optimal determinants”. DNA marker in combination with tumor-based markers is expect to improve the accuracy of diagnosis. The goal is if oncologists can determine through simple blood test if the recurrence of breast cancer is high they in turn then recommend a more aggressive therapy it may prevent the breast cancer from recurring. It is the hope of study authors that DNA predictors through blood test will see more clinical trials and then in turn be available for patients diagnosed with breast cancer very soon. Dr. Seify treats patients who are considering breast cancer reconstruction after breast cancer diagnosis. For the overwhelming majority of women the diagnosis will bring many different decisions have to be made. Dr. Seify and his staff work closely with each individual patient helping them to navigate not only the treatment decisions but also the necessary paperwork and insurance concerns that conservatives. Dr. Seify is able to offer many different breast reconstruction options to patients as a board-certified ASAP’s surgeon. Options include traditional methods including tram flap using tissue expanders as well as fat transfer and stem cell therapies. Patients who are diagnosed with breast cancer are encouraged to contact Dr. Seify’s office and schedule a consultation.